Website profile

Indian Pharma Post

Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com

  • 186articles · 30d
  • 15+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 90%with images
  • 243avg words
articles per day
Categories
  • Medical 137
  • Health & Wellness 101
  • Economy, Business & Finance 79
  • Health 74
  • Business & Industrial 64
  • Finance & Business 32
  • Science & Technology 21
  • News 14
Bylines

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@pharma_indian
indianpharmapost.com > people > bhushan-malpure-elevated-to-head-of-marketing-at-cipla-21817

Bhushan Malpure elevated to Head of Marketing at Cipla

16+ hour, 11+ min ago   (189+ words) Malpure comes with over 17 years of experience in pharmaceutical product management and marketing Bhushan Malpure has been elevated to Head of Marketing at Cipla, marking another step in his pharmaceutical marketing career with the company. Malpure has held several key…...

@pharma_indian
indianpharmapost.com > news > novartis-india-enters-exclusive-distribution-deal-with-nhpl-for-retina-portfolio-21758

Novartis India enters exclusive distribution deal with NHPL for retina portfolio

5+ day, 2+ hour ago   (167+ words) Novartis India Limited has acquired the exclusive rights to promote and distribute NHPL's retina portfolio across India Novartis India Limited has announced the signing of an exclusive promotion and distribution agreement with Novartis Healthcare Private Limited (NHPL) on September 8, 2026. This…...

@pharma_indian
indianpharmapost.com > healthcare > molbio-diagnostics-swings-to-profit-in-q1-fy27-as-truenat-test-kit-volumes-surge-21749

Molbio Diagnostics swings to profit in Q1 FY27 as Truenat test-kit volumes surge

5+ day, 16+ hour ago   (65+ words) India continued to account for the majority of Molbio's business, contributing 83.52% of revenue, while exports accounted for 16.48% Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership to…...

@pharma_indian
indianpharmapost.com > biopharma > indian-immunologicals-denies-manufacturing-low-quality-abhayrab-vials-found-in-delhi-seeks-probe-21739

Indian Immunologicals denies manufacturing low quality Abhayrab vials found in Delhi, seeks probe

6+ day, 14+ hour ago   (325+ words) Indian Immunologicals Limited (IIL) has clarified that the Abhayrab vaccine samples recently found to be Not of Standard Quality (NSQ) and misbranded were not manufactured by its vaccine division, Human Biologicals Institute (HBI). The clarification follows an enforcement action by the…...

Google News
indianpharmapost.com > news > zydus-pharmaceuticals-usa-inc-enters-into-us-59-million-settlement-agreement-21736

Zydus Pharmaceuticals USA Inc enters into US$ 5.9 million settlement agreement

1+ week, 7+ hour ago   (103+ words) ZPUI has agreed to pay a total of US$ 5.9 million to resolve above litigation matters Pursuant to the Settlement, ZPUI has agreed to pay a total of US$ 5.9 million to resolve above litigation matters. The Settlement contains a full and…...

@pharma_indian
indianpharmapost.com > hospitals > medulance-raises-rs-24-crore-in-series-a-2-round-21729

Medulance raises Rs. 24 crore in Series A-2 round

1+ week, 8+ hour ago   (300+ words) Medulance, a technology-enabled emergency healthcare and pre-hospital response company, has raised Rs. 24 crore in a Series A-2 funding round led by Auxano, Alkemi, Equentis and other angel investors. The company will use the fresh capital to expand its emergency response infrastructure…...

@pharma_indian
indianpharmapost.com > news > dadachanji-group-launches-kaisha-pharma-with-45-million-investment-21725

Dadachanji Group launches KAISHA Pharma with €45 million Investment

1+ week, 12+ hour ago   (202+ words) The Dadachanji Group, whose promoters built pharmaceutical glass-packaging company Schott Kaisha before exiting the venture in 2021, has launched KAISHA Pharma, marking its return to the segment with an initial investment of €45 million as it targets Indian and global pharmaceutical and…...

@pharma_indian
indianpharmapost.com > drug-approval > lupin-gets-us-fda-nod-for-modafinil-tablets-21717

Lupin gets US FDA nod for Modafinil tablets

1+ week, 1+ day ago   (155+ words) Global pharmaceutical major Lupin Limited has received approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP, 100 mg and 200 mg. The approved tablets are bioequivalent to Provigil, the reference listed drug…...

@pharma_indian
indianpharmapost.com > news > sun-pharma-joins-white-house-push-on-us-drug-pricing-21654

Sun Pharma joins White House push on US drug pricing

1+ week, 5+ day ago   (69+ words) The agreement recognizes Sun Pharma’s investment in the US market by delaying Section 232 tariffs on innovative pharmaceutical products for more than two years Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push Sun Pharma joins White House push…...

@pharma_indian
indianpharmapost.com > interviews > we-recently-launched-aminosaaya-system-in-india-dr-purushottam-sutar-product-business-development-manager-south-asia-hitachi-high-tech-india-72

We recently launched AminoSAAYA System in India: Dr. Purushottam Sutar, Product & Business Development Manager - South Asia, Hitachi High-Tech India

1+ week, 6+ day ago   (55+ words) Dr. Rajesh Nair appointed CEO of Park Group of Hospitals India cuts malaria cases and deaths by nearly 80% over a decade IPC launches 12 reference standards to strengthen quality of phytopharma Cipla’s InvaGen plant in New York gets VAI status from…...